Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 in Ulin Regional Hospital Banjarmasin
Background: Corona Virus Disease (COVID-19) has become a global pandemic and has spread to more than 200 countries including Indonesia. South Kalimantan is one of the provinces in Indonesia that has a high COVID-19 mortality rate (case fatality rate 4.1%). Information about characteristic of mortality patients with SARS-CoV-2 infection in Indonesia was limited. The objective of this study to describe clinical characteristics of COVID-19-confirmed deaths at Ulin Regional Hospital Banjarmasin, as a referral hospital in South Kalimantan
Methods: Medical records of 108 hospitalized patients dying with COVID-19 between March until August 2020 were collected. The recorded information included gender, age, onset and severity of disease, comorbidities, symptoms, signs, and laboratory findings
Results: The 108 confirmed cases of COVID-19 deaths were mostly male (73.1%) aged <65 years old (85.2%). About 84% of the cases had at least one comorbidity or more, like hypertension (44.4%), obesity (38%), and diabetes mellitus (32.4%). Common early symptoms were fever (91.7%) and shortness of breath (89.8%). Laboratory findings included lympocytopenia and eosinophilopenia (80.6% and 72.2%), increased neutrophil lymphocyte ratio (NLR; 86.1%), decreased absolute lymphocyte count (ALC; 72.2%), and hyponatremia (55.6%). Elevated C-reactive protein (CRP; 92.6%), lactate dehydrogenase (LDH; 91.7%), serum glutamic oxaloacetic transaminases (SGOT; 82.4%), and creatinine levels (57.4%). The majority of non survivors were severe-critical stage with severe acute respiratory distress syndrome (ARDS).
Conclusion: In this depictive study, patients with comorbidities and severe-critical stage are at risk of death. Laboratory abnormalities were common in non survivors. Shortness of breath may indicate poor prognosis of COVID-19.
Organization WH. Coronavirus Update. Geneva, https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=Cj0KCQiA3Y-ABhCnARIsAKYDH7sv2HW-9qXRBPM30UOmjKxCwzQDOL59CvLnTidAF8ABi8AR2a-CBeEaAj4qEALw_wcB (2020).
Indonesia KKR. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Jakarta, https://covid19.go.id/p/protokol/pedoman-pencegahan-dan-pengendalian-coronavirus-disease-covid-19 (2020).
Nasional KPC-19 dan PE. Indonesia’s Task Force for COVID-19. Jakarta, 2020.
Fu L, Wang B, Yuan T, et al. Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in China: A Systematic Review and Meta-Analysis. J Infect 2020; 80: 656–665.
Nagpal P, Narayanasamy S, Vidholia A, et al. Imaging of COVID-19 Pneumonia: Patterns, Pathogenesis, and Advances. Br J Radiol 2020; 93: 20200538.
Indonesia KKR. Indonesia’s Emerging Infection for COVID-19. Jakarta, https://infeksiemerging.kemkes.go.id/ (2020).
Karyono D, Wicaksana A. Current Prevalence, Characteristics, and Comorbidities of Patients with COVID-19 in Indonesia. J Community Empower Heal 2020; 3: 82–89.
Selatan DKPK. Informasi Terbaru COVID-19 di Kalimantan Selatan. Banjarmasin, http://dinkes.kalselprov.go.id/berita/informasi-terbaru-covid-19-di-kalimantan-selatan-8-november-2020.html (2020).
Li X, Wang L, Yan S, et al. Clinical Characteristics of 25 Death Cases with COVID-19: A Retrospective Review of Medical Records in a Single Medical Center, Wuhan, China. Int J Infect Dis IJID Off Publ Int Soc Infect Dis 2020; 94: 128–132.
Palmieri L, Vanacore N, Donfrancesco C, et al. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci 2020; 75: 1796–1800.
Zhang B, Zhou X, Qiu Y, et al. Clinical Characteristics of 82 Cases of Death from COVID-19. PLoS One 2020; 15: e0235458.
Xie J, Tong Z, Guan X, et al. Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China. JAMA Netw Open 2020; 3: e205619.
Jin J-M, Bai P, He W, et al. Gender Differences in Patients with COVID-19: Focus on Severity and Mortality. Front Public Heal 2020; 8: 152.
Susilo A, Rumende C, Pitoyo C, et al. Coronavirus Disease 2019: Tinjauan Literatur Terkini. J Penyakit Dalam Indones 2020; 7: 45.
Zheng Z, Peng F, Xu B, et al. Risk Factors of Critical & Mortal COVID-19 Cases: A Systematic Literature Review and Meta-Analysis. J Infect 2020; 81: e16–e25.
Wortham JM, Lee JT, Althomsons S, et al. Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 923–929.
Noor FM, Islam MM. Prevalence and Associated Risk Factors of Mortality among COVID-19 Patients: A Meta-Analysis. J Community Health 2020; 45: 1270–1282.
Ejaz H, Alsrhani A, Zafar A, et al. COVID-19 and Comorbidities: Deleterious Impact on Infected Patients. J Infect Public Health 2020; 13: 1833–1839.
Steinberg E, Wright E, Kushner B. In Young Adults with COVID-19, Obesity is Associated with Adverse Outcomes. West J Emerg Med 2020; 21: 752–755.
Hajifathalian K, Kumar S, Newberry C, et al. Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City. Obesity (Silver Spring) 2020; 28: 1606–1612.
Allali G, Marti C, Grosgurin O, et al. Dyspnea: The Vanished Warning Symptom of COVID-19 Pneumonia. J Med Virol 2020; 92: 2272–2273.
Xie J, Covassin N, Fan Z, et al. Association between Hypoxemia and Mortality in Patients with COVID-19. Mayo Clin Proc 2020; 95: 1138–1147.
Fan BE, Chong VCL, Chan SSW, et al. Hematologic Parameters in Patients with COVID-19 Infection. American Journal of Hematology 2020; 95: E131–E134.
Usul E, Şan İ, Bekgöz B, et al. Role of Hematological Parameters in COVID-19 Patients in the Emergency Room. Biomark Med 2020; 14: 1207–1215.
Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382: 1708–1720.
Jesenak M, Brndiarova M, Urbancikova I, et al. Immune Parameters and COVID-19 Infection - Associations with Clinical Severity and Disease Prognosis. Front Cell Infect Microbiol 2020; 10: 364.
Bloom PP, Meyerowitz EA, Reinus Z, et al. Liver Biochemistries in Hospitalized Patients with COVID-19. Hepatology. Epub ahead of print May 2020. DOI: 10.1002/hep.31326.
Cheng Y, Luo R, Wang K, et al. Kidney Disease is Associated with In-Hospital Death of Patients with COVID-19. Kidney Int 2020; 97: 829–838.
Poggiali E, Zaino D, Immovilli P, et al. Lactate Dehydrogenase and C-Reactive Protein as Predictors of Respiratory Failure in CoVID-19 Patients. Clin Chim Acta 2020; 509: 135–138.
Kermali M, Khalsa RK, Pillai K, et al. The Role of Biomarkers in Diagnosis of COVID-19 - A Systematic Review. Life Sci 2020; 254: 117788.
Han Y, Zhang H, Mu S, et al. Lactate Dehydrogenase, a Risk Factor of Severe COVID-19 Patients: A Retrospective and Observational Study. medRxiv 2020; 2020.03.24.20040162.
Ferrari D, Motta A, Strollo M, et al. Routine Blood Tests as a Potential Diagnostic Tool for COVID-19. Clin Chem Lab Med 2020; 58: 1095–1099.
Frontera JA, Valdes E, Huang J, et al. Prevalence and Impact of Hyponatremia in Patients with Coronavirus Disease 2019 in New York City. Crit Care Med 2020; 48: e1211–e1217.
Tezcan ME, Dogan Gokce G, Sen N, et al. Baseline Electrolyte Abnormalities would be Related to Poor Prognosis in Hospitalized Coronavirus Disease 2019 Patients. New Microbes New Infect 2020; 37: 100753.
Yang X, Yu Y, Xu J, et al. Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. Lancet Respir Med 2020; 8: 475–481.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution Share-Alike (CC BY-SA).
4. The Creative Commons Attribution Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under “the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violation.